These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37817141)

  • 21. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
    Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
    Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a Conformational Equilibrium That Determines the Efficacy and Functional Selectivity of the μ-Opioid Receptor.
    Okude J; Ueda T; Kofuku Y; Sato M; Nobuyama N; Kondo K; Shiraishi Y; Mizumura T; Onishi K; Natsume M; Maeda M; Tsujishita H; Kuranaga T; Inoue M; Shimada I
    Angew Chem Int Ed Engl; 2015 Dec; 54(52):15771-6. PubMed ID: 26568421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulfhydryl groups on opioid receptors revisited. Evidence for two sulfhydryl groups at or near the active site of the mu opioid receptor.
    Ofri D; Simon EJ
    Receptor; 1992; 2(2):109-19. PubMed ID: 1335327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
    Zhorov BS; Ananthanarayanan VS
    Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Photoswitchable Tethered Ligands that Target the μ-Opioid Receptor.
    Lahmy R; Hübner H; Lachmann D; Gmeiner P; König B
    ChemMedChem; 2023 Dec; 18(23):e202300228. PubMed ID: 37817331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct domains of the mu-opioid receptor control uncoupling and internalization.
    Celver J; Xu M; Jin W; Lowe J; Chavkin C
    Mol Pharmacol; 2004 Mar; 65(3):528-37. PubMed ID: 14978231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural Basis of μ-Opioid Receptor-Targeting by a Nanobody Antagonist.
    Yu J; Kumar A; Zhang X; Martin C; Raia P; Koehl A; Laeremans T; Steyaert J; Manglik A; Ballet S; Boland A; Stoeber M
    bioRxiv; 2023 Dec; ():. PubMed ID: 38106026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons.
    Minnis JG; Patierno S; Kohlmeier SE; Brecha NC; Tonini M; Sternini C
    Neuroscience; 2003; 119(1):33-42. PubMed ID: 12763066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor.
    Subramanian G; Paterlini MG; Portoghese PS; Ferguson DM
    J Med Chem; 2000 Feb; 43(3):381-91. PubMed ID: 10669565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers.
    Fan T; Varghese G; Nguyen T; Tse R; O'Dowd BF; George SR
    J Biol Chem; 2005 Nov; 280(46):38478-88. PubMed ID: 16159882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
    Zhang P; Johnson PS; Zöllner C; Wang W; Wang Z; Montes AE; Seidleck BK; Blaschak CJ; Surratt CK
    Brain Res Mol Brain Res; 1999 Oct; 72(2):195-204. PubMed ID: 10529478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective interactions between helix VIII of the human mu-opioid receptors and the C terminus of periplakin disrupt G protein activation.
    Feng GJ; Kellett E; Scorer CA; Wilde J; White JH; Milligan G
    J Biol Chem; 2003 Aug; 278(35):33400-7. PubMed ID: 12810704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, Synthesis, and Biological Evaluation of Bivalent Ligands Targeting Dopamine D
    Qian M; Vasudevan L; Huysentruyt J; Risseeuw MDP; Stove C; Vanderheyden PML; Van Craenenbroeck K; Van Calenbergh S
    ChemMedChem; 2018 May; 13(9):944-956. PubMed ID: 29451744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential response to morphine of the oligomeric state of μ-opioid in the presence of δ-opioid receptors.
    Golebiewska U; Johnston JM; Devi L; Filizola M; Scarlata S
    Biochemistry; 2011 Apr; 50(14):2829-37. PubMed ID: 21361347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the Putative Binding Site of a Benzimidazole Opioid (Etazene) and Its Metabolites at µ-Opioid Receptor: A Human Liver Microsomal Assay and Systematic Computational Study.
    Chaturvedi K; Hewamanna I; Pandey P; Khan W; Wang YH; Chittiboyina AG; Doerksen RJ; Godfrey M
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanism of ligand-induced activation or inhibition of μ- and κ-opioid receptors.
    Yuan S; Palczewski K; Peng Q; Kolinski M; Vogel H; Filipek S
    Angew Chem Int Ed Engl; 2015 Jun; 54(26):7560-3. PubMed ID: 25968837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calmodulin binding to G protein-coupling domain of opioid receptors.
    Wang D; Sadée W; Quillan JM
    J Biol Chem; 1999 Jul; 274(31):22081-8. PubMed ID: 10419536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous opioid agonist treatment dose-dependently regulates mu-opioid receptors and dynamin-2 in mouse spinal cord.
    Zhang Q; Purohit V; Yoburn BC
    Synapse; 2005 Jun; 56(3):123-8. PubMed ID: 15765525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone activation of mu-opioid receptors mutated at a histidine residue lining the opioid binding cavity.
    Spivak CE; Beglan CL; Seidleck BK; Hirshbein LD; Blaschak CJ; Uhl GR; Surratt CK
    Mol Pharmacol; 1997 Dec; 52(6):983-92. PubMed ID: 9415708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A constitutively internalizing and recycling mutant of the mu-opioid receptor.
    Segredo V; Burford NT; Lameh J; Sadée W
    J Neurochem; 1997 Jun; 68(6):2395-404. PubMed ID: 9166733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.